Literature DB >> 25529391

The effectiveness of a rehabilitation programme for Chinese cancer survivors: A pilot study.

Hui Zhang1, Yuqiu Zhou1, Yuxia Cui1, Jinwei Yang1.   

Abstract

Cancer survivors have experienced high stress which impairs psychological functioning and decreases quality of life (QOL). This study aims to assess the mediating effect of self-efficacy on mood disturbance and QOL, and determine the effectiveness of a 12 week rehabilitation programme to improve self-efficacy as well as improve mood disturbance and QOL in Chinese cancer survivors. A total of 47 cancer patients were randomly assigned into the experimental (n = 24) and control (n = 23) groups. The participants in the experimental group received cancer-related education, progressive muscle relaxation and emotional support. Self-reported questionnaires, including General Self-efficacy Scale (GSES), Profile of Mood States Scale-Short Form (POMS-SF) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) were collected in pre- and post-intervention. Findings from this study indicated that self-efficacy was a complete mediator between mood disturbance and QOL, and the 12 week rehabilitation programme had a positive effect on self-efficacy, mood disturbance and QOL for Chinese cancer survivors.
© 2014 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  cancer survivor; mediator; mood disturbance; quality of life; rehabilitation programme; self-efficacy

Mesh:

Year:  2014        PMID: 25529391     DOI: 10.1111/ijn.12370

Source DB:  PubMed          Journal:  Int J Nurs Pract        ISSN: 1322-7114            Impact factor:   2.066


  2 in total

1.  Predicting health-related quality of life in cancer patients receiving chemotherapy: a structural equation approach using the self-control model.

Authors:  Yu-Ri Park; Eun-Young Park; Jung-Hee Kim
Journal:  BMC Health Serv Res       Date:  2017-11-09       Impact factor: 2.655

2.  Utility of cooling patches to prevent hand-foot syndrome caused by pegylated liposomal doxorubicin in breast cancer patients.

Authors:  Yan-Fu Zheng; Xin Fu; Xiao-Xu Wang; Xiao-Jing Sun; Xiao-Dan He
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.